PROFOUND MEDICAL CORP. Class of Warrant or Right, Outstanding
PROFOUND MEDICAL CORP. (PROF) had Class of Warrant or Right, Outstanding of 0 shares as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2025-03-07
- 2024-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2022-12-31: Class of Warrant or Right, Outstanding 772.27K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2024-12-31 | 0.00 shares 10-K · filed 2025-03-07 |
| 2022-12-31 | 772.27K shares 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |